Cytocast Ltd., headquartered in Budapest, is a biotech startup specializing in cell simulation. Based on a wide range of available information on how cellular processes work, our software predicts protein complex changes in response to perturbations, such as diseases and drug treatments. With expertise in computational biology, bioinformatics, and high-performance computing, our team develops tools revolutionizing drug discovery and development in a personalized way. 

Our solution, Cytocast's Simulated Cell, is a high-performance computing tool that uses agent-based stochastic simulation to model protein interactions in a virtual cell. The tool integrates multi-omics data and models molecular interactions within cells, forming protein complexes pivotal for cellular functions. Through comprehensive analysis of cell behavior, we identify significant global differences between drug-treated and untreated cells. This enables us to predict drug effects and side effects by simulating alterations in complex formation across multiple tissue types.

Potential applications of Cytocast Simulated Cell

Cytocast Simulated Cell offers versatile applications, revolutionizing drug development, clinical practice, and industry practices for a more efficient and effective approach to healthcare.

Drug Discovery Revolution: Predicts drug effects and side effects, reducing costs and late-stage failures.
Clinical Trial Success: Increases success rates by vetting drug candidates before human trials, expediting treatment development.
Risk Mitigation: Identifies potential side effects early, ensuring safer drug candidates and market success.
Resource Efficiency: Cost-effectively tests numerous drug candidates in early stages, optimizing resource allocation.
Transition Assurance: Evaluates candidates moving from animal to human trials, reducing associated risks.
Precision Medicine: Customizes drug recommendations based on genetic profiles, improving treatment outcomes (under development).
Acquisition Due Diligence: Provides detailed analysis of potential drug acquisitions, aiding decision-making for pharmaceutical firms.

For More Information:

Explore our product brochure for more in-depth information about Cytocast’s technology.

Cytocast Simulated CellCytocast Kft

Cytocast Simulated Cell

Cytocast Kft

Cytocast Simulated Cell

Cytocast Kft

Cytocast Simulated Cell
Cytocast Kft